07:00 , Jun 1, 2009 |  BioCentury  |  Emerging Company Profile

Asuragen: Cutting pancreatic surgeries

Patients with pancreatic cancer and pancreatitis present with similar symptoms, and are often given ultrasound tests to confirm the presence or absence of lesions. About 15% of these tests are inconclusive, and as a result...
07:00 , Aug 7, 2008 |  BC Innovations  |  Tools & Techniques

Fly Screen for Flu Targets

A paper in Nature describes an RNAi screening strategy in Drosophila that could yield new host and viral targets to prevent or treat influenza infection, and possibly other viral infections. 1 But opinions vary over...
07:00 , Sep 3, 2007 |  BioCentury  |  Strategy

Innovation & leadership

Over the past two years, Back to School has been exploring the relationship between innovation and the economic returns from drug development and the creation of patient value. These discussions have argued that as pricing...
07:00 , Jul 31, 2006 |  BC Week In Review  |  Company News

Asuragen, Max Planck Society, Rockefeller University deal

The university granted Asuragen a nonexclusive license to microRNAs for use in cancer diagnostics. In a separate deal, Garching Innovation GmbH, the technology transfer arm of Max Plank, granted Asuragen coexclusive rights to use about...
00:22 , Jun 2, 2006 |  BC Extra  |  Financial News

Asuragen raises $49 million

Ambion spin-off Asuragen (Austin, Texas) raised $49 million in a series A round led by Telegraph Hill Partners. Growth Capital Partners and other undisclosed Ambion investors also participated in the round. Asuragen also said it...
08:00 , Mar 6, 2006 |  BC Week In Review  |  Company News

Ambion, Applied Biosystems deal

ABI completed its previously announced acquisition of the research products division of Ambion for about $273 million in cash (see BioCentury, Jan 2). Ambion Inc. , Austin, Texas   Applied Biosystems Group (ABI), Foster City,...
08:00 , Feb 27, 2006 |  BC Week In Review  |  Company News

Ambion sales and marketing update

Ambion launched an expression profiling service for microRNA analysis. Ambion Inc. , Houston, Texas   Business: Supply/Service  ...
08:00 , Jan 16, 2006 |  BC Week In Review  |  Company News

Asuragen management update

Asuragen Inc. , Austin, Texas   Business: Cancer   Hired: Matt Winkler as CEO, formerly CEO of Ambion Inc.  ...
08:00 , Jan 2, 2006 |  BC Week In Review  |  Company News

Ambion, Applied Biosystems deal

ABI will acquire the research products division of Ambion for about $273 million in cash. The deal includes Ambion's sample prep, RNAi, micro RNA and gene expression and array products. Ambion's diagnostics and service businesses...
01:12 , Dec 28, 2005 |  BC Extra  |  Top Story

ABI buying Ambion's research products

Applied Biosystems (ABI) will acquire the research products division of Ambion (Austin, Texas) for about $273 million in cash. The deal includes Ambion's sample prep, RNAi, micro RNA, and gene expression and array products. Ambion's...